GX EJ7 (Epivir 300 mg)
Generic Name: lamivudine
Pill with imprint GX EJ7 is Gray, Four-sided and has been identified as Epivir 300 mg. It is supplied by GlaxoSmithKline.
Epivir is used in the treatment of hiv infection; hepatitis b; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Epivir 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GX EJ7
Epivir
- Generic Name
- lamivudine
- Imprint
- GX EJ7
- Strength
- 300 mg
- Color
- Gray
- Size
- 17.00 mm
- Shape
- Four-sided
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GlaxoSmithKline
- National Drug Code (NDC)
- 00173-0714 (Discontinued)
- Inactive Ingredients
-
ferrosoferric oxide,
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol,
polysorbate 80,
sodium starch glycolate type A potato,
titanium dioxide
Note: Inactive ingredients may vary.
More about Epivir (lamivudine)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (2)
- Drug images
- Pricing & coupons
- Generic availability
- En español
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Patient resources
- Drug Information
- Epivir (Advanced Reading)
- Epivir (Lamivudine Oral Solution)
- Epivir (Lamivudine Tablets)
Professional resources
Other formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.